REED ELIZABETH E
SEC insider (Form 3/4/5 filer). CIK 0001283303. Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX). 43 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in SAN DIEGO, CA.
Companies REED ELIZABETH E has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Officer, Chief Legal Officer and GC
REED ELIZABETH E
CIK: 0001283303
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Travere Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (43 total)
- Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect21.9K shares at avg. $62.03$1.4M - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect13.9K shares at avg. $62.63$869K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect300 shares at avg. $65.31$20K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect37.5K shares at avg. $15.46$580K - Sep 15, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect1.4K shares at avg. $63.69$89K - May 6, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect2.1K shares at avg. $43.95$91K - May 5, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect2.2K shares at avg. $46.65$101K - May 4, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect20K shares at avg. $45.00$900K - May 4, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect20K shares at avg. $17.96$359K - May 4, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect4.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 21,926 | $62.03 | $1,359,971 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 13,874 | $62.63 | $868,965 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 300 | $65.31 | $19,593 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 37,500 | $15.46 | $579,750 | Direct |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 1,400 | $63.69 | $89,166 | Direct |
| May 6, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 2,076 | $43.95 | $91,240 | Direct |
| May 5, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 2,174 | $46.65 | $101,417 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 20,000 | $45.00 | $900,000 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 20,000 | $17.96 | $359,200 | Direct |
| May 4, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 4,250 | - | $0 | Direct |
1-10 of 43 transactions